Health Catalyst, Inc. (HCAT) vs NRx Pharmaceuticals, Inc. (NRXP)
A side-by-side comparison of Health Catalyst, Inc. and NRx Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HCAT
Health Catalyst, Inc.
$1.81HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
NRXP
NRx Pharmaceuticals, Inc.
$2.90HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT
Total return — HCAT vs NRXP
growth of $100 · dividends reinvested · last 7yHCAT -95.5% (-35.8%/yr)NRXP -97.3% (-40.2%/yr)HCAT compounded faster over this window
HCAT NRXP
HCAT vs NRXP: by the numbers
- •HCAT is the larger company ($133M vs $126M market cap).
- •Both run net losses; HCAT's is the smaller (-90.61% vs -691.81% net margin).
Metrics side by side
Valuation
| Metric | HCAT | NRXP |
|---|---|---|
| P/S ratio | 0.46 | 36.99 |
| P/B ratio | 1.32 | N/A |
| EV / EBITDA | 75.18 | N/A |
| FCF yield | 9.79% | N/A |
Profitability
| Metric | HCAT | NRXP |
|---|---|---|
| Gross margin | 33.47% | 58.78% |
| Operating margin | -11.60% | -1324.41% |
| Net margin | -90.61% | -691.81% |
| ROE | -262.64% | N/A |
| ROIC | -21.42% | N/A |
Growth (annualized)
| Metric | HCAT | NRXP |
|---|---|---|
| Revenue CAGR (5Y) | 6.24% | N/A |
| Total return CAGR (5Y) | -48.35% | -49.61% |
Frequently asked
- How have HCAT and NRXP total returns compared?
- Over the past 5 years, HCAT delivered -48.35% and NRXP delivered -49.61% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Health Catalyst ROENRx Pharmaceuticals ROEHealth Catalyst operating marginNRx Pharmaceuticals operating marginHealth Catalyst revenue growthNRx Pharmaceuticals revenue growthHealth Catalyst free cash flowNRx Pharmaceuticals free cash flow
Health Catalyst & NRx Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.